Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-24

FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for fosphenytoin sodium submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

SUPPL AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)